Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression - PubMed (original) (raw)
Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression
Gang Peng et al. Blood. 2007.
Abstract
HIV-1 recognition by, interaction with, and/or infection of CD4(+)CCR5(+) tissue macrophages and dendritic cells (DCs) play important roles in HIV-1 transmission and pathogenesis. By comparison, circulating CD4(+)CCR5(+) monocytes appear relatively resistant to HIV-1, and a fundamental unresolved question involves deciphering restriction factors unique to this precursor population. Not only do monocytes, relative to macrophages, possess higher levels of the innate resistance factor APOBEC3G, but we uncovered APOBEC3A, not previously associated with anti-HIV activity, as being critical in monocyte resistance. Inversely correlated with susceptibility, silencing of APOBEC3A renders monocytes vulnerable to HIV-1. Differences in promiscuity of monocytes, macrophages, and DCs can be defined, at least partly, by disparities in APOBEC expression, with implications for enhancing cellular defenses against HIV-1.
Figures
Figure 1
Differential HIV infection of monocytes, DCs, and macrophages. Peripheral-blood monocytes were processed immediately or cultured as described (“Materials and methods, Monocute isolation and differentiation to macrophages and dendritic cells”) to generate immature DCs and differentiated macrophages. (A) By flow-cytometry analysis using antibodies specific to CD14 and DC-SIGN, the 3 populations were phenotypically distinct. (B) Cultures of monocytes, DCs, and macrophages were incubated with HIV-1BaL for 90 minutes, washed, and incubated for 12 to 14 days. Media aliquots were removed every third day for p24 ELISA and replaced with fresh DMEM containing antibiotics and serum. Representative of 4 experiments (day 14 after infection; *P < .001, #P < .05) (SEM). (C) Transmission electron microscopy (EM) of macrophage infected with HIV-1 for 10 days, demonstrating intracellular budding and accumulation of virions (original magnification, × 20,000) using a Zeiss EM10 Microscope (LEO Electron Microscopy, Oberkochen, Germany). (D) Dual-color flow-cytometry analysis of CD4 and CCR5 expression and single-color annexin II staining on monocytes, macrophages, and DCs.
Figure 2.
HIV susceptibility and resistance gene expression. (A) Monocytes, DCs, and macrophages were prepared and RNA was extracted and processed for microarray analysis using the Affymetrix system. Relative transformed expression intensity values were calculated within probe set (row) and hierarchically clustered (“Materials and methods, Oligonucleotide microarray data processing and analysis”), and the corresponding heat map and dendrogram are shown here (red indicates above-average expression; black, average expression; and green, below-average expression for genes associated with HIV resistance and susceptibility). Some genes were represented by multiple probe sets that often fall within the same cluster. Those that show distinct expression behavior may suggest the presence of splice variants (eg, Dicer 1 in clusters 2 and 4). (B) Using the clusters from panel A, parallel line plots by cluster-compare gene-expression profiles in monocytes, DCs, and macrophages from 3 donors. (C) Monocytes, DCs, and macrophages were unstimulated or treated with LPS for 1 hour and RNA was extracted and processed for microarray analysis using the Affymetrix system. Data were treated as in panel A. Data shown are for all 11 probe sets corresponding to the APOBEC cytidine deaminase gene superfamily, represented on the U133Plus2 chip. (D) Parallel line plot comparing APOBEC3 family gene-expression profiles in monocytes, DCs, and macrophages from 3 donors for the 6 probe sets having more than 50% present calls (206632_s_at - 3B, 204205_at - 3G, 209584_x_at - 3C, 210873_x_at - 3A, 214995_s_at - 3G/ 3F, 214994_at - 3F).
Figure 3
Expression of APOBEC3 family genes during monocyte differentiation to macrophages. (A) Mean (± SEM) gene-expression level in S10 units (similar to log base 10 units) over 3 donors for 3 APOBEC3 family genes (A,G,F) in monocytes (Mono), dendritic cells (imDC), and macrophages (Mac). *P < .001 between monocyte hA3A and DCs or macrophage hA3A. (B) By RT-PCR, monocyte, DC, and macrophage expression of APOBEC3G and 3A in a representative donor. GAPDH was used as a control gene. (C) Protein levels of APOBEC3G and APOBEC3A were monitored in monocytes, DCs, and macrophages by Western blot using specific antibodies with GAPDH as the loading control.
Figure 4
Kinetics of APOBEC3 family gene expression during monocyte differentiation to macrophages. Peripheral-blood monocytes were harvested immediately after isolation or cultured for indicated days as adherent cells and their RNA were analyzed by RT-PCR for the expression of hA3A, hA3F, hA3G, PKR, and GAPDH (inset). Graph represents the APOBEC-to-GAPDH ratio (representative kinetics, n = 2).
Figure 5
IFN coordinately enhances macrophage APOBEC3 expression and decreases susceptibility to HIV-1. (A-B) Macrophages (n = 3 donors) were cultured in the presence or absence of 10 ng/mL IFNα or IFNγ for 4 hours or 100 ng/mL LPS for 1 hour and the RNA was processed for microarray analysis. The bar graph shows the fold change for hA3G (A) and hA3A (B) across treatments. (Insets) IFNα dose-response (0, 0.1, 1, 10 ng/mL; 4 hours) induction of hA3G (A) and hA3A (B) by RT-PCR. (C) Macrophages were infected or not with HIV-1BaL for 90 minutes, washed, and IFNα or IFNγ added once after infection at the indicated concentrations (0.1–10 ng/mL). HIV-1 infection was monitored by p24 levels in the supernatants (day 14 shown; *P < .005) (mean ± SEM).
Figure 6
Silencing of APOBEC3A blocks monocyte resistance to HIV. (A) Monocytes were transfected with siRNA sequences specific for hA3A or a control siRNA (siC) or mock transfected (electroporation control [EPC]) before infection with HIV. Two to 3 days after HIV-1 infection, cells were processed and tested for viral DNA synthesis by nested PCR. (B) Transfected monocytes were adhered and infected with HIV-1. Supernatants were harvested every third day for analysis of p24 levels by ELISA (day 13 shown; mean ± SE). Differences between electroporation control (EPC) and siRNA for hA3A were significant (*P < .05). (Inset) Monocytes transfected as described in (A) with siRNA specific for hA3G or control sequences (siC) were infected with HIV-1 and supernatants were tested for HIV p24. (C) Transfected cells were cultured for 48 hours and treated with IFNα (10 ng/mL) overnight before monitoring of hA3A and α tubulin protein levels by Western-blot analysis.
Similar articles
- Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1.
Tuttle DL, Harrison JK, Anders C, Sleasman JW, Goodenow MM. Tuttle DL, et al. J Virol. 1998 Jun;72(6):4962-9. doi: 10.1128/JVI.72.6.4962-4969.1998. J Virol. 1998. PMID: 9573265 Free PMC article. - Enhancing immunity to HIV through APOBEC.
Harris RS. Harris RS. Nat Biotechnol. 2008 Oct;26(10):1089-90. doi: 10.1038/nbt1008-1089. Nat Biotechnol. 2008. PMID: 18846074 No abstract available. - APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection.
Pion M, Granelli-Piperno A, Mangeat B, Stalder R, Correa R, Steinman RM, Piguet V. Pion M, et al. J Exp Med. 2006 Dec 25;203(13):2887-93. doi: 10.1084/jem.20061519. Epub 2006 Dec 4. J Exp Med. 2006. PMID: 17145955 Free PMC article. - Induction of innate immunity in control of mucosal transmission of HIV.
Wang Y, Lehner T. Wang Y, et al. Curr Opin HIV AIDS. 2011 Sep;6(5):398-404. doi: 10.1097/COH.0b013e3283499df7. Curr Opin HIV AIDS. 2011. PMID: 21734563 Review. - [Antiviral defense by APOBEC3 family proteins].
Takaori A. Takaori A. Uirusu. 2005 Dec;55(2):267-72. doi: 10.2222/jsv.55.267. Uirusu. 2005. PMID: 16557012 Review. Japanese.
Cited by
- CRL4-DCAF1 Ubiquitin Ligase Dependent Functions of HIV Viral Protein R and Viral Protein X.
Dobransky A, Root M, Hafner N, Marcum M, Sharifi HJ. Dobransky A, et al. Viruses. 2024 Aug 17;16(8):1313. doi: 10.3390/v16081313. Viruses. 2024. PMID: 39205287 Free PMC article. Review. - Anelloviruses versus human immunity: how do we control these viruses?
Timmerman AL, Schönert ALM, van der Hoek L. Timmerman AL, et al. FEMS Microbiol Rev. 2024 Jan 12;48(1):fuae005. doi: 10.1093/femsre/fuae005. FEMS Microbiol Rev. 2024. PMID: 38337179 Free PMC article. Review. - Vaccinia-related kinase 2 variants differentially affect breast cancer growth by regulating kinase activity.
Gwak SH, Lee J, Oh E, Lee D, Han W, Kim J, Kim KT. Gwak SH, et al. Oncol Res. 2023 Dec 28;32(2):421-432. doi: 10.32604/or.2023.031031. eCollection 2023. Oncol Res. 2023. PMID: 38186576 Free PMC article. - Mitochondrial double-stranded RNA triggers induction of the antiviral DNA deaminase APOBEC3A and nuclear DNA damage.
Wick C, Moghadasi SA, Becker JT, Fanunza E, Oh S, Bournique E, Buisson R, Harris RS. Wick C, et al. J Biol Chem. 2023 Sep;299(9):105073. doi: 10.1016/j.jbc.2023.105073. Epub 2023 Jul 19. J Biol Chem. 2023. PMID: 37474103 Free PMC article. - APOBECs: Our fickle friends?
Dudley JP. Dudley JP. PLoS Pathog. 2023 May 18;19(5):e1011364. doi: 10.1371/journal.ppat.1011364. eCollection 2023 May. PLoS Pathog. 2023. PMID: 37200235 Free PMC article. No abstract available.
References
- Wahl SM, Orenstein JM, Smith PD. Macrophage functions in HIV-1 infection. In: Gupta S., editor. 1996 in Immunology of HIV Infection. New York, NY: Plenum Press; 1996. pp. 303–336.
- Orenstein JM, Fox C, Wahl SM. Macrophages as a source of HIV during opportunistic infections. Science. 1997;276:1857–1861. - PubMed
- Garbuglia AR, Zaccarelli M, Calcaterra S, Cappiello G, Marini R, Benedetto A. Dynamics of viral load in plasma and HIV DNA in lymphocytes during highly active antiretroviral therapy (HAART): high viral burden in macrophages after 1 year of treatment. J Chemother. 2001;13:188–194. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials